Tokyo, July 26 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058597) titled 'Prospective observational study for corticosteroid binding globulin abnormality in patients with hypoadrenocorticism' on July 25.
Study Type:
Observational
Primary Sponsor:
Institute - Wakayama Medical University
Condition:
Condition - Hypoadrenocorticism
Classification by malignancy - Others
Genomic information - YES
Objective:
Narrative objectives1 - Impact of Abnormal Corticosteroid-Binding Globulin (CBG) on Adrenal Hormone Testing and Clinical Features in Patients with Hypoadrenocorticism
Basic objectives2 - Others
Eligibility:
Age-lower limit - 18
years-old
=
Gender - Male and Female
Key inclusion criteria - Patients with suspected hypoadrenocorticism based on clinical symptoms and adrenal hormone tests in accordance with the treatment guidelines for hypoadrenocorticism. Healthy subjects who do not meet the exclusion criteria will be included.
Key exclusion criteria - 1) Patients receiving exogenous steroids
2) Pregnant women
Target Size - 200
Recruitment Status:
Recruitment status - Enrolling by invitation
Date of protocol fixation - 2023 Year 07 Month 31 Day
Date of IRB - 2023 Year 08 Month 01 Day
Anticipated trial start date - 2023 Year 08 Month 01 Day
Last follow-up date - 2028 Year 06 Month 19 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067001
Disclaimer: Curated by HT Syndication.
